Heel Softening Balm Base

1. INCI et CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Rôle dans la formule

Butyrospermum Parkii Butter is listed as a butter in this development reference. The recorded formula also lists Mangifera Indica Seed Butter and Squalane. Review the contribution to body and application feel in the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• Reference component allocation: 34% w/w.

Melt into the oil phase and continue shear through cooling to help keep Butyrospermum Parkii Butter from becoming grainy.

4. Sources réglementaires et conformité mondiale

• The record provides guidance for development; it does not certify the supplied material or completed cosmetic; No approval of the final formula is represented.

5. Sécurité et évaluation des risques

The guide records a level for cosmetic formulation purposes; no drug approval or OTC status is conferred by this entry so assess patch response and stability in the final formula.

6. Stabilité et conditionnement

Keep bulk supplies closed, cool, and protected from sunlight; for oxidation-sensitive formulas, consider an airless or pump pack; confirm compatibility and stability using the selected formula and pack.

7. Formulations d'allégations (à faire / à éviter)

• The formulation note describes Butyrospermum Parkii Butter as part of a cosmetic direction focused on shea cushion.

• The ingredient record does not substantiate therapeutic results, cure claims, or unverified certification claims.
• The ingredient note for Butyrospermum Parkii Butter provides no basis for whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.

1. INCI et CAS

INCI: Mangifera Indica Seed Butter · CAS: 90063-86-8

2. Rôle dans la formule

Mangifera Indica Seed Butter is listed as a butter in this development reference. The recorded formula also lists Butyrospermum Parkii Butter and Squalane. Review the contribution to body and application feel in the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• The guide level assigned to this component is 16% w/w.

Melt with the oil phase.

4. Sources réglementaires et conformité mondiale

• The ingredient entry serves as a development reference; it does not authorize a particular grade or finished formula; The note should not be read as approval of the final formula.

5. Sécurité et évaluation des risques

The concentration shown is guidance for cosmetic formulation; the note establishes neither drug approval nor OTC-monograph status so patch response and stability should be checked on the finished product.

6. Stabilité et conditionnement

Keep the ingredient in cool, closed bulk storage away from sunlight; choose a package with oxidation sensitivity in view; follow with stability and packaging checks on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic concept for Mangifera Indica Seed Butter in this entry centers on mango-butter.

• The formulation note does not support drug effects, clinical cures, or unsupported product certifications.
• The formulation record for Mangifera Indica Seed Butter does not demonstrate skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.

1. INCI et CAS

INCI: Squalane · CAS: 111-01-3

2. Rôle dans la formule

Squalane is listed as an emollient in this development reference. The recorded formula also lists Butyrospermum Parkii Butter and Mangifera Indica Seed Butter. Review spreading, slip and the finish of the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• Reference component allocation: 14.8% w/w.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Sources réglementaires et conformité mondiale

• This note is supplied for formulation development; it establishes no approval for the raw material or the final product; This entry does not approve a completed product.

5. Sécurité et évaluation des risques

The guide records a level for cosmetic formulation purposes; the note establishes neither drug approval nor OTC-monograph status and the finished formula still needs patch and stability testing.

6. Stabilité et conditionnement

For bulk storage, avoid warmth and direct sun and keep the container closed; match the pack choice to the system's oxidation risk; confirm compatibility and stability using the selected formula and pack.

7. Formulations d'allégations (à faire / à éviter)

• The cosmetic formulation concept for Squalane centers on a light-emollient role.

• This ingredient reference cannot verify drug effects, cures, or certification claims that go beyond the documented ingredient information.
• This reference for Squalane should not be cited in support of whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.